RecruitingNCT05039216

Biobank for Inflammatory Chronic Diseases and Osteoporosis

Biobank for Inflammatory Chronic Diseases and Osteoporosis of TOULouse

Sponsor

University Hospital, Toulouse

Enrollment

2,000 participants

Start Date

Sep 13, 2021

Study Type

OBSERVATIONAL

Conditions

Rheumatoid Arthritis Osteoporosis Psoriatic Arthritis Spondyloarthritis

Summary

The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.

Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This is a biobank study — a research program that collects and stores blood, tissue, and other samples from patients with inflammatory joint diseases (like rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis) or osteoporosis. The samples will be used for future research into these conditions. **You may be eligible if...** - You have been diagnosed with rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, or primary or secondary osteoporosis - You are covered by national health insurance - You are able to give informed consent **You may NOT be eligible if...** - You are pregnant or breastfeeding - You are unable to give consent - You have severe anemia (hemoglobin below 10 g/L) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.